【结 构 式】 |
【药物名称】A-71497 【化学名称】(±)-7-(3-Aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxaldehyde hydrochloride 【CA登记号】134762-03-1 【 分 子 式 】C19H16ClF3N4O2 【 分 子 量 】424.81317 |
【开发单位】Abbott (Originator) 【药理作用】Antibacterial Drugs, ANTIINFECTIVE THERAPY, Chemical Delivery Systems, DRUG DELIVERY, Drug Delivery Systems, Naphthyridines |
合成路线1
Treatment of ethyl 2,6-dichloro-5-fluoronicotinylacetate (I) with ethyl orthoformate in refluxing acetic anhydride and then with 2,4-difluoroaniline in methylene chloride at room temperature gives the enaminoketo ester derivative (II). Cyclization of (II) with sodium hydride in THF gives ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate (III). Hydrolysis of (III) with hydrochloric acid yields 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid (IV). Condensation of (IV) with 3-tert-butoxycarbonylaminopyrrolidine in pyridine in the presence of triethylamine yields 7-(3-tert-butoxycarbonylaminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid (V). Sodium borohydride reduction of (V) in methanol followed by decarboxylation in the presence of toluenesulfonic acid yields the 7-(3-tert-butoxycarbonylaminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-1,2,3,4-tetrahydro-4-oxo-1,8-naphthyridine (VI). Acylation of (VI) with ethyl formate in THF in the presence of NaH and a catalytic amount of ethanol yields the 7-(3-tert-butoxycarbonylaminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-3-formyl-4-hydroxy-1,2-dihydro-1,8-naphthyridine (VII). Oxidation of (VII) with manganese dioxide in methanol gives 7-(3-tert-butoxycarbonylaminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-3-formyl-1,4-dihydro-4-oxo-1,8-naphthyridine (VIII). Hydrolysis of (VIII) in hydrochloric acid and dioxane gives A-71497.
【1】 Swanson, R.N.; Pernet, A.G.; Marsh, K.C.; Chu, D.T.W.; Lico, I.M.; Plattner, J.J.; Synthesis and biological properties of A-71497: A prodrug of tosufloxacin. 9th Int Symp Fut Trends Chemother 1990, 21. |
【2】 Chu, D.T.W.; A-71497. Drugs Fut 1990, 15, 12, 1171. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 19462 | 2,4-difluoroaniline; 2,4-difluorophenylamine;2,4-Difluoro-benzenamine;1-Amino-2,4-difluorobenzene | 367-25-9 | C6H5F2N | 详情 | 详情 |
(B) | 21310 | tert-butyl 3-pyrrolidinylcarbamate | 99724-19-3 | C9H18N2O2 | 详情 | 详情 |
(I) | 15228 | ethyl 3-(2,6-dichloro-5-fluoro-3-pyridinyl)-3-oxopropanoate | C10H8Cl2FNO3 | 详情 | 详情 | |
(II) | 15229 | ethyl (Z)-2-[(2,6-dichloro-5-fluoro-3-pyridinyl)carbonyl]-3-(2,4-difluoroanilino)-2-propenoate | C17H11Cl2F3N2O3 | 详情 | 详情 | |
(III) | 31219 | ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,2,3,4-tetrahydro[1,8]naphthyridine-3-carboxylate | C17H12ClF3N2O3 | 详情 | 详情 | |
(IV) | 31220 | 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,2,3,4-tetrahydro[1,8]naphthyridine-3-carboxylic acid | C15H8ClF3N2O3 | 详情 | 详情 | |
(V) | 31221 | 7-[3-[(tert-butoxycarbonyl)amino]-1-pyrrolidinyl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,2,3,4-tetrahydro[1,8]naphthyridine-3-carboxylic acid | C24H25F3N4O5 | 详情 | 详情 | |
(VI) | 31222 | tert-butyl 1-[8-(2,4-difluorophenyl)-3-fluoro-5-oxo-5,6,7,8-tetrahydro[1,8]naphthyridin-2-yl]-3-pyrrolidinylcarbamate | C23H25F3N4O3 | 详情 | 详情 | |
(VII) | 31223 | tert-butyl 1-[8-(2,4-difluorophenyl)-3-fluoro-6-formyl-5-hydroxy-7,8-dihydro[1,8]naphthyridin-2-yl]-3-pyrrolidinylcarbamate | C24H25F3N4O4 | 详情 | 详情 | |
(VIII) | 31224 | tert-butyl 1-[8-(2,4-difluorophenyl)-3-fluoro-6-formyl-5-oxo-5,8-dihydro[1,8]naphthyridin-2-yl]-3-pyrrolidinylcarbamate | C24H23F3N4O4 | 详情 | 详情 |